Literature DB >> 18664627

Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.

Harukiyo Kawamura1, Xiujuan Li, Katsutoshi Goishi, Laurens A van Meeteren, Lars Jakobsson, Stéphanie Cébe-Suarez, Akio Shimizu, Dan Edholm, Kurt Ballmer-Hofer, Lena Kjellén, Michael Klagsbrun, Lena Claesson-Welsh.   

Abstract

Vascular endothelial growth factor (VEGF)-A regulates vascular development and angiogenesis. VEGF isoforms differ in ability to bind coreceptors heparan sulfate (HS) and neuropilin-1 (NRP1). We used VEGF-A165 (which binds HS and NRP1), VEGF-A121 (binds neither HS nor NRP1), and parapoxvirus VEGF-E-NZ2 (binds NRP1 but not HS) to investigate the role of NRP1 in organization of endothelial cells into vascular structures. All 3 ligands induced similar level of VEGFR-2 tyrosine phosphorylation in the presence of NRP1. In contrast, sprouting angiogenesis in differentiating embryonic stem cells (embryoid bodies), formation of branching pericyte-embedded vessels in subcutaneous matrigel plugs, and sprouting of intersegmental vessels in developing zebrafish were induced by VEGF-A165 and VEGF-E-NZ2 but not by VEGF-A121. Analyses of recombinant factors with NRP1-binding gain- and loss-of-function properties supported the conclusion that NRP1 is critical for VEGF-induced sprouting and branching of endothelial cells. Signal transduction antibody arrays implicated NRP1 in VEGF-induced activation of p38MAPK. Inclusion of the p38MAPK inhibitor SB203580 in VEGF-A165-containing matrigel plugs led to attenuated angiogenesis and poor association with pericytes. Our data strongly indicate that the ability of VEGF ligands to bind NRP1 influences p38MAPK activation, and formation of functional, pericyte-associated vessels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664627      PMCID: PMC2572791          DOI: 10.1182/blood-2007-12-125856

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.

Authors:  E Landgren; P Schiller; Y Cao; L Claesson-Welsh
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

2.  Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.

Authors:  A M Dougher; H Wasserstrom; L Torley; L Shridaran; P Westdock; R E Hileman; J R Fromm; R Anderberg; S Lyman; R J Linhardt; J Kaplan; B I Terman
Journal:  Growth Factors       Date:  1997       Impact factor: 2.511

3.  Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.

Authors:  P Carmeliet; M G Lampugnani; L Moons; F Breviario; V Compernolle; F Bono; G Balconi; R Spagnuolo; B Oosthuyse; M Dewerchin; A Zanetti; A Angellilo; V Mattot; D Nuyens; E Lutgens; F Clotman; M C de Ruiter; A Gittenberger-de Groot; R Poelmann; F Lupu; J M Herbert; D Collen; E Dejana
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

4.  Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors.

Authors:  T Takahashi; A Fournier; F Nakamura; L H Wang; Y Murakami; R G Kalb; H Fujisawa; S M Strittmatter
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

5.  Neuropilin is a receptor for the axonal chemorepellent Semaphorin III.

Authors:  Z He; M Tessier-Lavigne
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Neuropilin is a semaphorin III receptor.

Authors:  A L Kolodkin; D V Levengood; E G Rowe; Y T Tai; R J Giger; D D Ginty
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.

Authors:  L M Wise; T Veikkola; A A Mercer; L J Savory; S B Fleming; C Caesar; A Vitali; T Makinen; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1.

Authors:  H Cai; R R Reed
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

9.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

10.  Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

Authors:  H Q Miao; S Soker; L Feiner; J L Alonso; J A Raper; M Klagsbrun
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  70 in total

1.  Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.

Authors:  Usman Yaqoob; Sheng Cao; Uday Shergill; Kumaravelu Jagavelu; Zhimin Geng; Meng Yin; Thiago M de Assuncao; Ying Cao; Anna Szabolcs; Snorri Thorgeirsson; Martin Schwartz; Ju Dong Yang; Richard Ehman; Lewis Roberts; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

4.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

5.  Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.

Authors:  Silvia Coma; Akio Shimizu; Michael Klagsbrun
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

Review 6.  Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Authors:  Prakash Vempati; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cytokine Growth Factor Rev       Date:  2013-11-27       Impact factor: 7.638

Review 7.  Signaling circuitry in vascular morphogenesis.

Authors:  Carmen M Warren; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

8.  Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury.

Authors:  Hong-Cai Wang; Bo-Ding Wang; Mao-Song Chen; Hai Chen; Cheng-Feng Sun; Gang Shen; Jian-Min Zhang
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

Review 9.  The role of semaphorins and their receptors in vascular development and cancer.

Authors:  Chenghua Gu; Enrico Giraudo
Journal:  Exp Cell Res       Date:  2013-02-17       Impact factor: 3.905

10.  Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Authors:  Esak Lee; Jacob E Koskimaki; Niranjan B Pandey; Aleksander S Popel
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.